[1]
Al-Qahtani, S.M., Bryzgalova, G., Efendić, S., Berggren, P.-O. and Portwood, N. 2016. Activation of hepatic AMPK by 17β-estradiol suppresses both nuclear receptor Nr2c2/TR4 and its downstream lipogenic targets, reduces gluconeogenic genes and improves insulin signaling. Disease and Molecular Medicine. 4, 4 (Dec. 2016), 55-67. DOI:https://doi.org/10.5455/dmm.20160929104837.